MedTrace Logo

Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO

NCT06025682 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 158

Last updated 2024-04-11

No results posted yet for this study

Summary

The goal of this observational study is to learn about infectious complications in patients affected by B-cell acute lymphoblastic leukemia treated with inotuzumab-ozogamicin (INO). The main question it aims to answer is:

• incidence of infectious complications (bacterial, fungal, viral) in patients receiving inotuzumab ozogamicin up to 60 days after the end of treatment

Conditions

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Livio Pagano · Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Roma

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-04
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06025682 on ClinicalTrials.gov